Literature DB >> 30390854

Enhanced Recovery After Surgery and Surgical Disparities.

Isabel C Marques1, Tyler S Wahl1, Daniel I Chu2.   

Abstract

Surgical disparities exist. Certain surgical populations suffer from disproportionately worse access, care, and outcomes in surgery. Opportunities exist to better identify, understand, and reduce these disparities. Enhanced Recovery After Surgery (ERAS) pathways use standardized perioperative processes and a multidisciplinary philosophy to deliver best-evidence surgical care to all patients. As a result, ERAS provides a uniquely pragmatic model for improving outcomes and reducing disparities in vulnerable surgical populations. The value of ERAS may therefore extend beyond its traditional benefits to the even greater pursuit of health equity.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ERAS; Health disparities; Interventions; Surgical disparities; Surgical outcomes

Mesh:

Year:  2018        PMID: 30390854     DOI: 10.1016/j.suc.2018.07.015

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

1.  Racial disparities in surgical outcomes of patients with Inflammatory Bowel Disease.

Authors:  Samuel R Montgomery; Paris D Butler; Chris J Wirtalla; Karole T Collier; Rebecca L Hoffman; Cary B Aarons; Scott M Damrauer; Rachel R Kelz
Journal:  Am J Surg       Date:  2018-05-12       Impact factor: 2.565

2.  Improving Equity, Diversity, and Inclusion in Plastic, Reconstructive, and Aesthetic Surgery in Canada: A Call to Action.

Authors:  Laura Snell; Chantal R Valiquette; Emma Avery; Syena Moltaji; Christopher R Forrest
Journal:  Plast Surg (Oakv)       Date:  2022-03-24       Impact factor: 0.558

3.  Patients undergoing colorectal surgery at a Veterans Affairs Hospital do not experience racial disparity in length of stay either before or after implementing an enhanced recovery pathway.

Authors:  C Rentas; S Baker; L Goss; J Richman; S J Knight; C Key; M Morris
Journal:  BMC Surg       Date:  2022-05-21       Impact factor: 2.030

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.